Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
Mohsen Mazidi(King's College London), Simon Gilbert(University of Oxford), Ling Yang(Tongji University), Johnathan Clarke(University of Oxford), Canqing Yu(Peking University), Dan Schmidt(University of Oxford), Richard Peto(University of Oxford), Robert Clarke(Nuffield Health), Alfred Pozarickij(University of Oxford), Pang Yao(Peking University), Hannah Fry(University of Oxford), Michael V. Holmes(University of Oxford), Christiana Kartsonaki(University of Oxford), Iona Y. Millwood(University of Oxford), Ka Hung Chan(University of Oxford), Robin Walters(Northeastern University), Derrick Bennett(American Council on Education), Saredo Said(Novo Nordisk (Finland)), Ruth Boxall(University of Oxford), Jun Lv(Shanghai Jiao Tong University), Neil Wright(University of Oxford), Huaidong Du(University of Oxford), Sushila Burgess, Ahmed Edris Mohamed(University of Oxford), Rory Collins(University of Oxford), Yiping Chen(Beijing University of Chinese Medicine), Liming Li(Peking University), Zhengming Chen(Population Council), Chen Wang(Shanghai University), Maxim Barnard(University of Oxford), Junshi Chen, Joanna M. M. Howson(University of Cambridge), Michael Hill(University of Ottawa), Pei Pei(Chinese Academy of Medical Sciences & Peking Union Medical College), Daniel Avery(University of Oxford)
Cited by 39
Related Papers
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|8.4k